CN Bio Launches Physiomimix Dili Assay Kit: Human 24, for Enhanced Preclinical Toxicology Testing
- All-in-one kit enables in-house, in vitro profiling of human drug-induced liver injury
- Rapid access to CN Bio’s FDA-recognized human DILI assay to optimize and de-risk drug candidate selection
- 24 replicates to support simultaneous assessment of up to eight conditions per kit